Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Obsidian OBE Stock Rule Based Trade Volatility Increases 20260418 What Dynamix DNMXU does that makes it resilient 020 20260508 CytoMed GDTC Stock Deal Activity Slight Rise 20260416 SRE DBA Sempra beats Q4 2025 EPS expectations posts modest revenue growth as shares edge lower Sabra SBRA Stock Market Pricing Steady Climb 20260415 Is Brandywine BDN stock priced below intrinsic value Q1 2026 Earnings Beat Estimates SWIM Latham Group Q4 2025 EPS exceeds consensus estimates yet shares drop 252 percent in todays trading ACNB Corp ACNB Stock Why Operational Efficiency Ticks Higher 20260422 MTRN Materion posts narrow Q4 2025 EPS miss shares climb slightly as investor confidence remains stable OTF Blue Owl delivers blowout Q4 2025 earnings with strong EPS beat and 120 percent year over year revenue growth Is Nuveen NBB stock expensive compared to peers Kaltura KLTR Q1 2026 Earnings EPS Surprise of 400 as Company Narrows Losses Inside the Lucrative and Secretive World of Orchid Breeding A MultiMillion Dollar Industry Jane Street Faces Lawsuit Alleging Insider Trading During Terra Ecosystem Collapse Dollar Retreats as Geopolitical Risks and Fed Policy Dominate Trader Focus authID AUID Q1 2026 Earnings Revenue NA Matching Views Google Advances Wearable AI with Upcoming Smart Glasses Release SEC Delays Tokenized Stock Trading Proposal Amid Pushback Crypto Exchange Stocks Slide HSY Q1 2026 Earnings Strong EPS Beat Drives Stock Higher TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines Viant Technology DSP Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges Parke Bancorp PKBK Edges Higher Support Holds as Stock Approaches Key Resistance EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization ELTK Q1 2026 Earnings Loss Per Share of 042 Shares Rise 608 Despite No Revenue Disclosure GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development PFXNZ Q1 2026 Earnings Earnings Beat Driven by Strong Investment Income and Portfolio Performance FRME Q1 2026 Earnings EPS Beats Estimates by Nearly 9 as Stock Edges Lower OUST Q1 2026 Earnings EPS Beat Drives Positive Market Reaction